source
- US Treasury proposes COINS Act rules that restrict biotech investment in China but leave big pharma licensing deals untouchedThe U.S. Treasury Department released draft regulations that add biotechnology to the Comprehensive Outbound Investment National Security (COINS) Act, labeling pharmaceutical compounds as prohibite…
- US Treasury drafts rules to curb American investment in Chinese biotech firmsThe Treasury Department has released draft regulations that would impose broad restrictions on U.S. companies and venture capital firms investing in or acquiring drug and biotechnology assets linke…